RAAV-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
US9226976B2 · kind B2 · utility
32Cited by
10References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2012 |
| Grant date | Jan 5, 2016 |
| Priority date | — |
| Expiry date | May 2, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2750/14143
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to isolated nucleic acids and rAAV-based compositions, methods and kits useful for treating genetic diseases (e.g., alpha-1 antitrypsin deficiency).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.